Robert Burns Analyst PerformanceVice President of Equity Research at HC WainwrightRobert Burns is a stock analyst at HC Wainwright focused in the healthcare sector, covering 55 publicly traded companies. Over the past year, Robert Burns has issued 141 stock ratings, including buy, hold, and sell recommendations. While full access to Robert Burns' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robert Burns' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings453 Last 6 YearsBuy Recommendations89.56% 403 Buy RatingsCompanies Covered55 Unique Companies Ratings Distribution450RatingsDistribution of strong buy, buy, hold, and sell ratings by Robert Burns.RatingPercentageCount Strong Buy0.4%2 ratings Buy89.1%401 ratings Hold10.0%45 ratings Sell0.4%2 ratingsOut of 450 total stock ratings issued by Robert Burns at HC Wainwright, the majority (89.1%) have been Buy recommendations, followed by 10.0% Hold, 0.4% Strong Buy, and 0.4% Sell.Best & Worst CallsBest Call000000.0%TNGXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call0000.0%EFTRNov 2023Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ87.3% of companies on NASDAQ48 companiesOTCMKTS5.5% of companies on OTCMKTS3 companiesNYSE3.6% of companies on NYSE2 companiesNYSEAMERICAN3.6% of companies on NYSEAMERICAN2 companiesRobert Burns, an analyst at HC Wainwright, currently covers 55 companies listed on NASDAQ, OTCMKTS, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare54 companies98.2%Miscellaneous1 company1.8%Robert Burns of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY49 companies89.1%PHARMACEUTICALS5 companies9.1%Miscellaneous1 company1.8% About Robert BurnsMr. Burns is a Vice President of Equity Research at H.C. Wainwright whose research focuses on the biotechnology sector. Mr. Burns’ expertise spans the universe of next-generation approaches to the treatment of cancer, with particular focus on the immuno-oncology and precision oncology sectors. Prior to joining H.C. Wainwright, Mr. Burns worked at BMO Capital Markets as an equity research associate covering Major Pharma under analyst Alex Arfaei; he followed multiple Top 10 pharmaceutical firms and focused on tracking developments in the oncology arena, particularly within the context of checkpoint inhibition and immunotherapy. Mr. Burns’ educational background includes a Master’s degree in Medical Science from Boston University School of Medicine as well as a Bachelor’s degree in Chemistry from Brooklyn College. Mr. Burns also attended Boston University School of Medicine as a medical student for three years.Follow on LinkedIn Robert Burns' Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBCAXBicara Therapeutics11/11/2026Lower Price Target$10.18$36.00Buy$0.0000.00% ROITNGXTango Therapeutics11/10/2026Lower Price Target$22.74$67.00Buy$0.0000.00% ROIZYMEZymeworks11/10/2026Boost Price Target$30.81$56.00Buy$0.0000.00% ROIBNTXBioNTech11/9/2026Lower Price Target$87.51$110.00Buy$0.0000.00% ROICOGTCogent Biosciences11/9/2026Boost Price Target$31.65$56.00Buy$0.0000.00% ROIRVMDRevolution Medicines11/6/2026Boost Price Target$177.65$350.00Buy$0.0000.00% ROIEXELExelixis11/2/2026Boost Price Target$69.39$78.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics10/29/2026Reiterated Rating$1.83Buy$0.0000.00% ROITNGXTango Therapeutics10/29/2026Reiterated Rating$22.23$68.00Buy$0.0000.00% ROIHURATuHURA Biosciences10/27/2026Reiterated Rating$2.03$10.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. PBLSParabilis Medicines10/22/2026Initiated Coverage$27.85$40.00Buy$0.0000.00% ROIELVNEnliven Therapeutics10/19/2026Boost Price Target$37.32$73.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/16/2026Boost Price Target$24.95$36.00Buy$0.0000.00% ROIAVBPArriVent BioPharma10/8/2026Lower Price Target$16.89$27.00Buy$0.0000.00% ROICRBUCaribou Biosciences10/8/2026Downgrade$0.62Neutral$0.0000.00% ROICGEMCullinan Therapeutics10/2/2026Reiterated Rating$14.53$35.00Buy$0.0000.00% ROIBLSMBlossomHill Therapeutics9/30/2026Reiterated Rating$21.37Buy$0.0000.00% ROITLPPFTelix Pharmaceuticals9/30/2026Reiterated Rating$12.40Buy$0.0000.00% ROIACETAdicet Bio9/28/2026Boost Price Target$7.29$34.00Buy$0.0000.00% ROICGEMCullinan Therapeutics9/25/2026Boost Price Target$15.44$35.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals9/25/2026Reiterated Rating$11.37$20.00Buy$0.0000.00% ROIACETAdicet Bio9/18/2026Reiterated Rating$8.89$27.00Buy$0.0000.00% ROICRDFCardiff Oncology9/15/2026Upgrade$1.31Buy$0.0000.00% ROITLXTelix Pharmaceuticals9/15/2026Reiterated Rating$12.77$20.00Buy$0.0000.00% ROICOGTCogent Biosciences9/15/2026Reiterated Rating$33.11$55.00Buy$0.0000.00% ROIPMVPPMV Pharmaceuticals9/4/2026Reiterated Rating$1.24$5.00Buy$0.0000.00% ROITLPPFTelix Pharmaceuticals9/2/2026Reiterated Rating$11.08Buy$0.0000.00% ROITLXTelix Pharmaceuticals9/2/2026Reiterated Rating$10.85$20.00Buy$0.0000.00% ROIBLSMBlossomHill Therapeutics9/1/2026Initiated Coverage$18.30$35.00Buy$0.0000.00% ROIBLSMBlossomHill Therapeutics9/1/2026Initiated Coverage$18.99$35.00Buy$0.0000.00% ROIRVMDRevolution Medicines8/27/2026Boost Price Target$215.44$280.00Buy$0.0000.00% ROIZYMEZymeworks8/26/2026Boost Price Target$27.47$55.00Buy$0.0000.00% ROIINBXInhibrx Biosciences8/24/2026Initiated Coverage$103.63$245.00Buy$0.0000.00% ROIRLAYRelay Therapeutics8/20/2026Boost Price Target$20.74$29.00Buy$0.0000.00% ROIELTXElicio Therapeutics8/18/2026Reiterated Rating$3.02Buy$0.0000.00% ROITNGXTango Therapeutics8/18/2026Boost Price Target$25.29$68.00Buy$0.0000.00% ROIAVBPArriVent BioPharma8/17/2026Boost Price Target$29.51$47.00Buy$0.0000.00% ROICGEMCullinan Therapeutics8/17/2026Reiterated Rating$20.34$30.00Buy$0.0000.00% ROIORICOric Pharmaceuticals8/10/2026Boost Price Target$13.50$27.00Buy$0.0000.00% ROIIMMXImmix Biopharma8/10/2026Boost Price Target$9.72$25.00Buy$0.0000.00% ROIThis is likely to EXPLODE (Ad)Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.Watch Dr Weiss's free video to learn how to protect your moneyZYMEZymeworks8/5/2026Boost Price Target$23.56$51.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics7/31/2026Downgrade$7.01Negative$0.0000.00% ROIKPTIKaryopharm Therapeutics7/31/2026Downgrade$7.01$3.00Neutral$0.0000.00% ROIPRLDPrelude Therapeutics7/29/2026Reiterated Rating$4.64$8.00Buy$0.0000.00% ROITLPPFTelix Pharmaceuticals7/28/2026Reiterated Rating$10.02Buy$0.0000.00% ROINUVBNuvation Bio7/27/2026Boost Price Target$6.45$21.00Buy$0.0000.00% ROIOKUROnKure Therapeutics7/20/2026Lower Price Target$4.18$21.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics7/15/2026Reiterated Rating$4.39Buy$0.0000.00% ROINRIXNurix Therapeutics7/10/2026Boost Price Target$24.69$34.00Buy$0.0000.00% ROIELVNEnliven Therapeutics7/9/2026Boost Price Target$50.80$64.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals7/7/2026Reiterated Rating$12.15$20.00Buy$0.0000.00% ROIMOLNMolecular Partners7/6/2026Reiterated Rating$3.98Buy$0.0000.00% ROIRVMDRevolution Medicines7/6/2026Reiterated Rating$190.26$195.00Buy$0.0000.00% ROIEXELExelixis7/2/2026Reiterated Rating$53.96$56.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics6/18/2026Reiterated Rating$9.40Buy$0.0000.00% ROIELTXElicio Therapeutics6/15/2026Boost Price Target$14.85$23.00Buy$0.0000.00% ROINRIXNurix Therapeutics6/10/2026Reiterated Rating$15.64$32.00Buy$0.0000.00% ROITNGXTango Therapeutics6/9/2026Boost Price Target$31.12$66.00Buy$0.0000.00% ROIADCTADC Therapeutics6/8/2026Downgrade$1.03Neutral$0.0000.00% ROIORICOric Pharmaceuticals6/8/2026Reiterated Rating$7.50$25.00Buy$0.0000.00% ROIFATEFate Therapeutics6/8/2026Reiterated Rating$1.98$7.00Buy$0.0000.00% ROICGEMCullinan Therapeutics6/8/2026Reiterated Rating$13.51$30.00Buy$0.0000.00% ROIRADXRadiopharm Theranostics6/4/2026Initiated Coverage$4.49$6.00Buy$0.0000.00% ROIZYMEZymeworks6/3/2026Reiterated Rating$24.11$46.00Buy$0.0000.00% ROIAKTSAktis Oncology6/2/2026Boost Price Target$19.81$35.00Buy$0.0000.00% ROIRVMDRevolution Medicines6/1/2026Boost Price Target$163.40$195.00Buy$0.0000.00% ROICRDFCardiff Oncology6/1/2026Downgrade$1.90Neutral$0.0000.00% ROIELTXElicio Therapeutics5/28/2026Reiterated Rating$10.77$17.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics5/28/2026Reiterated Rating$5.28$7.00Buy$0.0000.00% ROIRLAYRelay Therapeutics5/26/2026Boost Price Target$13.53$28.00Buy$0.0000.00% ROIIMMXImmix Biopharma5/22/2026Boost Price Target$8.90$20.00Buy$0.0000.00% ROICRBUCaribou Biosciences5/11/2026Boost Price Target$1.94$11.00Buy$0.0000.00% ROIEXELExelixis5/7/2026Boost Price Target$48.70$56.00Buy$0.0000.00% ROICOGTCogent Biosciences5/6/2026Boost Price Target$36.97$55.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics5/6/2026Boost Price Target$9.41$13.00Buy$0.0000.00% ROIADCTADC Therapeutics5/5/2026Reiterated Rating$3.64$8.00Buy$0.0000.00% ROINUVBNuvation Bio5/5/2026Reiterated Rating$4.45$17.00Buy$0.0000.00% ROIFATEFate Therapeutics5/4/2026Boost Price Target$1.53$7.00Buy$0.0000.00% ROIRLAYRelay Therapeutics4/29/2026Boost Price Target$13.03$25.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics4/29/2026Boost Price Target$2.70$11.00Buy$0.0000.00% ROICGEMCullinan Therapeutics4/28/2026Boost Price Target$12.85$30.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics4/27/2026Boost Price Target$4.70$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics4/27/2026Reiterated Rating$16.68$32.00Buy$0.0000.00% ROIBNTXBioNTech4/27/2026Reiterated Rating$105.46$130.00Buy$0.0000.00% ROIRVMDRevolution Medicines4/22/2026Reiterated Rating$148.90Buy$0.0000.00% ROIMOLNMolecular Partners4/22/2026Reiterated Rating$4.49$13.00Buy$0.0000.00% ROIALLOAllogene Therapeutics4/14/2026Boost Price Target$3.04$12.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals4/13/2026Reiterated Rating$10.54$20.00Buy$0.0000.00% ROIREPLReplimune Group4/13/2026Downgrade$4.77Sell$0.0000.00% ROINRIXNurix Therapeutics4/10/2026Reiterated Rating$16.24$32.00Buy$0.0000.00% ROIURGENT: If you own a home, please review the map below. (Ad)More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.See the map and get the full details on what this means for youTLXTelix Pharmaceuticals4/7/2026Reiterated Rating$9.09$20.00Buy$0.0000.00% ROICRBUCaribou Biosciences4/7/2026Reiterated Rating$1.95$9.00Buy$0.0000.00% ROIORICOric Pharmaceuticals4/2/2026Reiterated Rating$7.47$25.00Buy$0.0000.00% ROIBNTXBioNTech3/31/2026Lower Price Target$85.25$130.00Buy$0.0000.00% ROIAKTSAktis Oncology3/31/2026Boost Price Target$16.54$33.00Buy$0.0000.00% ROIBCAXBicara Therapeutics3/31/2026Boost Price Target$19.04$42.00Buy$0.0000.00% ROIIMMXImmix Biopharma3/27/2026Boost Price Target$8.72$15.00Buy$0.0000.00% ROIELVNEnliven Therapeutics3/26/2026Boost Price Target$35.53$56.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics3/25/2026Lower Price Target$5.44$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics3/24/2026Reiterated Rating$14.69$32.00Buy$0.0000.00% ROIACETAdicet Bio3/23/2026Lower Price Target$6.92$27.00Buy$0.0000.00% ROIRLAYRelay Therapeutics3/23/2026Boost Price Target$9.91$19.00Buy$0.0000.00% ROIADCTADC Therapeutics3/23/2026Boost Price Target$3.88$8.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/23/2026Boost Price Target$4.45$13.00Buy$0.0000.00% ROIOKUROnKure Therapeutics3/16/2026Lower Price Target$3.78$27.00Buy$0.0000.00% ROIMOLNMolecular Partners3/16/2026Reiterated Rating$4.22$13.00Buy$0.0000.00% ROIELTXElicio Therapeutics3/13/2026Boost Price Target$10.90$17.00Buy$0.0000.00% ROIORICOric Pharmaceuticals3/13/2026Reiterated Rating$11.76$25.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics3/13/2026Reiterated Rating$4.05$7.00Buy$0.0000.00% ROIAKTSAktis Oncology3/9/2026Initiated Coverage$18.81$30.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/6/2026Boost Price Target$25.25$44.00Buy$0.0000.00% ROIBBOTBridgeBio Oncology Therapeutics3/6/2026Boost Price Target$9.89$29.00Buy$0.0000.00% ROITNGXTango Therapeutics3/6/2026Boost Price Target$16.80$27.00Buy$0.0000.00% ROIZYMEZymeworks3/6/2026Boost Price Target$24.80$46.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/24/2026Boost Price Target$12.46$25.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics2/18/2026Reiterated Rating$9.40$15.00Buy$0.0000.00% ROIEXELExelixis2/12/2026Boost Price Target$42.94$54.00Buy$0.0000.00% ROIEXELExelixis2/3/2026Reiterated Rating$42.81$52.00Buy$0.0000.00% ROIHURATuHURA Biosciences2/3/2026Reiterated Rating$0.52$10.00Buy$0.0000.00% ROICATXPerspective Therapeutics1/30/2026Boost Price Target$4.26$12.00Buy$0.0000.00% ROINRIXNurix Therapeutics1/29/2026Boost Price Target$17.87$32.00Buy$0.0000.00% ROICRDFCardiff Oncology1/28/2026Reiterated Rating$2.00$10.00Buy$0.0000.00% ROIMOLNMolecular Partners1/27/2026Initiated Coverage$4.09$13.00Buy$0.0000.00% ROIMOLNMolecular Partners1/27/2026Initiated Coverage$4.00$13.00Buy$0.0000.00% ROIEXELExelixis1/27/2026Boost Price Target$43.61$52.00Buy$0.0000.00% ROIACETAdicet Bio1/21/2026Reiterated Rating$7.90$50.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals1/21/2026Reiterated Rating$7.73$20.00Buy$0.0000.00% ROIBCAXBicara Therapeutics1/14/2026Reiterated Rating$17.53Buy$0.0000.00% ROINUVBNuvation Bio1/12/2026Lower Price Target$8.03$17.00Buy$0.0000.00% ROIHURATuHURA Biosciences1/9/2026Reiterated Rating$0.75$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics1/8/2026Boost Price Target$10.71$27.00Buy$0.0000.00% ROIEXELExelixis1/8/2026Boost Price Target$44.79$52.00Buy$0.0000.00% ROICOGTCogent Biosciences1/6/2026Boost Price Target$34.26$52.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals12/22/2025Reiterated Rating$7.80$20.00Buy$0.0000.00% ROIBNTXBioNTech12/11/2025Reiterated Rating$96.00$140.00Buy$0.0000.00% ROINUVBNuvation Bio12/11/2025Boost Price Target$7.90$18.00Buy$0.0000.00% ROINRIXNurix Therapeutics12/10/2025Boost Price Target$19.55$31.00Buy$0.0000.00% ROINUVBNuvation Bio12/1/2025Reiterated Rating$8.05$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics11/20/2025Boost Price Target$9.10$26.00Buy$0.0000.00% ROIZYMEZymeworks11/18/2025Boost Price Target$23.90$32.00Buy$0.0000.00% ROIThis is likely to EXPLODE (Ad)Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.Watch Dr Weiss's free video to learn how to protect your moneyORICOric Pharmaceuticals11/14/2025Boost Price Target$13.08$23.00Buy$0.0000.00% ROICOGTCogent Biosciences11/13/2025Boost Price Target$35.26$50.00Buy$00.0000.00% ROIBNTXBioNTech11/10/2025Boost Price Target$103.14$140.00Buy$00.0000.00% ROIACETAdicet Bio11/7/2025Boost Price Target$10.83$144.00Buy$0.0000.00% ROIRVMDRevolution Medicines11/6/2025Boost Price Target$59.34$73.00Buy$000.0000.00% ROICRBUCaribou Biosciences11/5/2025Boost Price Target$2.17$9.00Buy$0.0000.00% ROIEXELExelixis11/5/2025Boost Price Target$39.06$49.00Buy$00.0000.00% ROICOGTCogent Biosciences11/4/2025Reiterated Rating$15.50$21.00Buy$00.0000.00% ROIMGNXMacroGenics11/3/2025Reiterated Rating$1.66$2.00Neutral$0.0000.00% ROIFATEFate Therapeutics10/31/2025Upgrade$1.29$5.00Buy$0.0000.00% ROIZYMEZymeworks10/27/2025Reiterated Rating$17.87Buy$00.0000.00% ROINRIXNurix Therapeutics10/27/2025Lower Price Target$11.98$28.00Buy$00.0000.00% ROIREPLReplimune Group10/27/2025Upgrade$8.80$12.00Buy$00.0000.00% ROIRPTXRepare Therapeutics10/27/2025Lower Price Target$1.90$3.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics10/20/2025Set Price Target$5.74$7.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics10/20/2025Initiated Coverage$5.86$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/20/2025Reiterated Rating$9.84$33.00Buy$00.0000.00% ROIADCTADC Therapeutics10/16/2025Lower Price Target$4.24$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/14/2025Lower Price Target$9.72$33.00Buy$00.0000.00% ROIZYMEZymeworks10/14/2025Set Price Target$18.11$26.00Buy$00.0000.00% ROIKPTIKaryopharm Therapeutics10/13/2025Upgrade$5.50$15.00Buy$0.0000.00% ROICATXPerspective Therapeutics10/3/2025Reiterated Rating$3.49$10.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics9/23/2025Reiterated Rating$1.01$5.00Buy$0.0000.00% ROINUVBNuvation Bio9/19/2025Reiterated Rating$3.16$10.00Buy$0.0000.00% ROICATXPerspective Therapeutics9/19/2025Reiterated Rating$3.29$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics9/12/2025Reiterated Rating$6.62$24.00Buy$00.0000.00% ROIIMMXImmix Biopharma9/12/2025Boost Price Target$2.22$8.00Buy$00.0000.00% ROITLXTelix Pharmaceuticals9/10/2025Lower Price Target$9.66$20.00Buy$00.0000.00% ROIBNTXBioNTech9/8/2025Reiterated Rating$112.46$136.00Buy$000.0000.00% ROIREPLReplimune Group9/8/2025Reiterated Rating$6.33Neutral$00.0000.00% ROIRLAYRelay Therapeutics8/26/2025Lower Price Target$3.51$14.00Buy$00.0000.00% ROIOKUROnKure Therapeutics8/26/2025Reiterated Rating$2.75$34.00Buy$0.0000.00% ROIBCAXBicara Therapeutics8/22/2025Lower Price Target$11.63$40.00Buy$00.0000.00% ROICGEMCullinan Therapeutics8/21/2025Initiated Coverage$7.47$24.00Buy$00.0000.00% ROIORICOric Pharmaceuticals8/14/2025Lower Price Target$9.83$19.00Buy$00.0000.00% ROIBNTXBioNTech8/14/2025Lower Price Target$111.87$136.00Buy$00.0000.00% ROIAVBPArriVent BioPharma8/12/2025Reiterated Rating$17.42$42.00Buy$00.0000.00% ROIEXELExelixis8/12/2025Lower Price Target$37.41$46.00Buy$00.0000.00% ROIBDTXBlack Diamond Therapeutics8/11/2025Lower Price Target$2.40$10.00Buy$0.0000.00% ROICOGTCogent Biosciences8/6/2025Lower Price Target$11.36$21.00Buy$00.0000.00% ROICRDFCardiff Oncology8/6/2025Lower Price Target$2.57$10.00Buy$0.0000.00% ROIREPLReplimune Group7/23/2025Downgrade$2.81Neutral$00.0000.00% ROIACETAdicet Bio7/23/2025Upgrade$12.03$64.00Strong-Buy$0.0000.00% ROIAVBPArriVent BioPharma7/22/2025Reiterated Rating$21.55$40.00Buy$00.0000.00% ROIELTXElicio Therapeutics7/17/2025Boost Price Target$9.05$13.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics7/16/2025Downgrade$4.24Neutral$0.0000.00% ROINRIXNurix Therapeutics7/14/2025Lower Price Target$12.42$34.00Buy$00.0000.00% ROIKPTIKaryopharm Therapeutics7/11/2025Initiated Coverage$5.00$27.00Buy$00.0000.00% ROICOGTCogent Biosciences7/8/2025Boost Price Target$9.33$22.00Buy$00.0000.00% ROITLXTelix Pharmaceuticals7/3/2025Initiated Coverage$16.50$23.00Buy$00.0000.00% ROIMy public warning after 55 years of watching the markets (Ad)Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.See Martin Weiss's full warning before this risk spreads furtherZYMEZymeworks7/3/2025Reiterated Rating$12.89$13.00Neutral$00.0000.00% ROIREPLReplimune Group7/3/2025Reiterated Rating$9.55$22.00Buy$00.0000.00% ROIELVNEnliven Therapeutics7/2/2025Boost Price Target$19.65$48.00Buy$00.0000.00% ROIEXELExelixis6/30/2025Boost Price Target$43.67$53.00Buy$00.0000.00% ROIBNTXBioNTech6/25/2025Reiterated Rating$105.09$138.00Buy$00.0000.00% ROIBNTXBioNTech6/16/2025Lower Price Target$106.57$138.00Buy$00.0000.00% ROIEXELExelixis6/12/2025Reiterated Rating$41.43$47.00Buy$00.0000.00% ROIBNTXBioNTech6/5/2025Boost Price Target$111.21$145.00Buy$00.0000.00% ROIIMMXImmix Biopharma6/4/2025Reiterated Rating$2.11$7.00Buy$0.0000.00% ROIBNTXBioNTech5/22/2025Reiterated Rating$99.09$134.00Buy$00.0000.00% ROICOGTCogent Biosciences5/20/2025Lower Price Target$5.03$12.00Buy$00.0000.00% ROIBCAXBicara Therapeutics5/16/2025Lower Price Target$14.47$41.00Buy$00.0000.00% ROIHURATuHURA Biosciences5/16/2025Reiterated Rating$3.84$12.00Buy$0.0000.00% ROIELVNEnliven Therapeutics5/15/2025Boost Price Target$19.89$40.00Buy$00.0000.00% ROIRVMDRevolution Medicines5/14/2025Reiterated Rating$40.01$72.00Buy$000.0000.00% ROIBNTXBioNTech5/14/2025Reiterated Rating$93.89$134.00Buy$00.0000.00% ROIAVBPArriVent BioPharma5/14/2025Boost Price Target$18.76$40.00Buy$00.0000.00% ROICRDFCardiff Oncology5/9/2025Boost Price Target$2.63$18.00Buy$0.0000.00% ROIORICOric Pharmaceuticals5/5/2025Reiterated Rating$5.67$21.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics5/5/2025Reiterated Rating$0.89$5.00Buy$0.0000.00% ROICRBUCaribou Biosciences4/28/2025Reiterated Rating$0.77$3.00Buy$0.0000.00% ROITNGXTango Therapeutics4/14/2025Reiterated Rating$1.41$13.00Buy$00.0000.00% ROIPRLDPrelude Therapeutics4/8/2025Reiterated Rating$0.65$5.00Buy$0.0000.00% ROIBCAXBicara Therapeutics4/7/2025Lower Price Target$10.57$44.00Buy$00.0000.00% ROIHURATuHURA Biosciences4/3/2025Lower Price Target$3.48$12.00Buy$0.0000.00% ROINRIXNurix Therapeutics4/2/2025Reiterated Rating$10.47$36.00Buy$00.0000.00% ROIELTXElicio Therapeutics4/2/2025Reiterated Rating$4.95$10.00Buy$00.0000.00% ROIBNTXBioNTech4/1/2025Lower Price Target$91.06$145.00Buy$00.0000.00% ROIADCTADC Therapeutics3/31/2025Reiterated Rating$1.49$8.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/31/2025Reiterated Rating$2.20$10.00Buy$0.0000.00% ROIEXELExelixis3/27/2025Reiterated Rating$37.01$40.00Buy$00.0000.00% ROIMGNXMacroGenics3/25/2025Lower Price Target$1.96$2.00Neutral$0.0000.00% ROIELVNEnliven Therapeutics3/21/2025Boost Price Target$20.92$39.00Buy$00.0000.00% ROIPMVPPMV Pharmaceuticals3/20/2025Reiterated Rating$1.28$5.00Buy$0.0000.00% ROICRBUCaribou Biosciences3/19/2025Reiterated Rating$0.95$9.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/19/2025Reiterated Rating$2.45$10.00Buy$0.0000.00% ROIALLOAllogene Therapeutics3/19/2025Lower Price Target$1.69$8.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics3/18/2025Boost Price Target$1.71$12.00Buy$0.0000.00% ROIOKUROnKure Therapeutics3/18/2025Lower Price Target$4.82$34.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/13/2025Initiated Coverage$2.66$10.00Buy$0.0000.00% ROINUVBNuvation Bio3/10/2025Lower Price Target$2.03$10.00Buy$0.0000.00% ROIZYMEZymeworks3/10/2025Boost Price Target$11.09$13.00Neutral$00.0000.00% ROIRPTXRepare Therapeutics3/7/2025Lower Price Target$1.19$5.00Buy$0.0000.00% ROIRLAYRelay Therapeutics3/7/2025Reiterated Rating$3.48$16.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/7/2025Reiterated Rating$21.81$39.00Buy$00.0000.00% ROIHURATuHURA Biosciences3/3/2025Initiated Coverage$2.41$13.00Buy$0.0000.00% ROIRVMDRevolution Medicines3/3/2025Boost Price Target$40.74$73.00Buy$000.0000.00% ROICRDFCardiff Oncology2/28/2025Boost Price Target$4.06$17.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/21/2025Reiterated Rating$7.63$21.00Buy$00.0000.00% ROIEXELExelixis2/13/2025Reiterated Rating$32.80$40.00Buy$00.0000.00% ROIREPLReplimune Group2/13/2025Boost Price Target$13.79$22.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/11/2025Reiterated Rating$11.23$21.00Buy$00.0000.00% ROIIMMXImmix Biopharma2/10/2025Reiterated Rating$2.01$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics1/29/2025Boost Price Target$19.56$36.00Buy$00.0000.00% ROIATRAAtara Biotherapeutics1/28/2025Reiterated Rating$7.37Neutral$0.0000.00% ROIEXELExelixis1/27/2025Reiterated Rating$32.38$40.00Buy$00.0000.00% ROIBCAXBicara Therapeutics1/27/2025Boost Price Target$11.60$45.00Buy$00.0000.00% ROINUVBNuvation Bio1/23/2025Boost Price Target$2.65$11.00Buy$0.0000.00% ROIATRAAtara Biotherapeutics1/22/2025Reiterated Rating$6.05Neutral$0.0000.00% ROIAVBPArriVent BioPharma1/22/2025Boost Price Target$25.31$39.00Buy$00.0000.00% ROIREPLReplimune Group1/22/2025Boost Price Target$11.85$21.00Buy$0.0000.00% ROICOGTCogent Biosciences1/14/2025Lower Price Target$7.57$14.00Buy$00.0000.00% ROIRLAYRelay Therapeutics1/14/2025Reiterated Rating$4.78$16.00Buy$0.0000.00% ROIORICOric Pharmaceuticals1/13/2025Reiterated Rating$8.29$21.00Buy$0.0000.00% ROIEXELExelixis1/10/2025Boost Price Target$34.50$40.00Buy$00.0000.00% ROIBCAXBicara Therapeutics12/6/2024Initiated Coverage$19.54$42.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.